Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/1996
05/02/1996WO1996012696A1 Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
05/02/1996WO1996012503A1 Remedy for diseases caused by il-6 production
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
05/02/1996WO1996012484A1 Antianemic agent containing iron and difructose
05/02/1996CA2203280A1 Modified factor vii
05/01/1996EP0709386A1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/01/1996EP0709096A2 Pharmaceutical conditionning unit containing plasminogen activators for a multiple bolus delivery
05/01/1996EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists
05/01/1996CN1121430A Inmunization adjusting, anti-inflamation agent
04/1996
04/30/1996US5512304 Method of preparing a thromboplastin extract
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/25/1996WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist
04/25/1996WO1996012021A2 Nematode-extracted serine protease inhibitors and anticoagulant proteins
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996WO1996011941A1 Dipeptide derivatives, process for producing them and medicaments containing these compounds
04/25/1996WO1996011697A1 Thrombin inhibitors
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2202379A1 Dipeptide derivatives, process for their production and pharmaceutical agents containing these compounds
04/24/1996EP0707648A1 Platelet glycoprotein v gene and uses
04/24/1996EP0707595A1 Peptidase resistant thrombin receptor peptide ligand
04/24/1996EP0489070B1 Novel inhibitors of thrombin
04/24/1996EP0450097B1 Benzoheterocyclic compounds
04/24/1996CN1121077A New peptide compounds derived from boronic acid, process for preparing them and pharmaceutical compositions containing them
04/24/1996CN1120936A Process for the production of a pharmaceutical composition comprising an ATP anologue
04/23/1996US5510369 Pyrrolidine thrombin inhibitors
04/23/1996US5510330 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
04/23/1996CA1338260C Human protein s, a plasma protein regulator of hemostasis
04/21/1996CA2160975A1 Use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
04/18/1996WO1996011021A2 Treatment of tissues to reduce subsequent response to injury
04/18/1996DE4436772A1 Neues Dipeptid-Derivat, Verfahren zu seiner Herstellung sowie diese Verbindung enthaltende Arzneimittel New dipeptide derivative, process for its preparation and pharmaceutical compositions containing this compound
04/18/1996CA2202272A1 Treatment of tissues to reduce subsequent response to injury
04/17/1996EP0707067A2 A novel gene coding thrombin-like protease
04/17/1996EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods
04/17/1996EP0706517A1 Pyridazinone derivatives with pharmaceutical activity
04/17/1996EP0706398A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters
04/17/1996EP0654028B1 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments
04/17/1996CN1031570C Process for preparation of pyrazolopyridine compound
04/16/1996US5508385 Protease inhibitor; antiulcer agents, antiinflammatory agents; treating pancreatitis
04/16/1996US5508292 Administering anticoagulants to humans to treat atherosclerotic diseases; cardiovascular disorders
04/16/1996US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury
04/11/1996WO1996010584A1 Process for extracting high-purity von willebrand factor
04/10/1996EP0705901A2 Method of separating recombinant pro-factor IX from recombinant factor IX
04/10/1996EP0705846A1 High molecular weight and low molecular weight fractions of von Willebrand factor
04/10/1996EP0705274A1 Method and composition for treating thrombosis
04/10/1996EP0705103A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments
04/10/1996EP0507870B1 Polyhemoglobin stabilized by purine derivatives and glutathione
04/10/1996EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
04/10/1996CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
04/10/1996CN1120334A Heterocyclic derivatives as platelet aggregation inhibitors
04/10/1996CN1120047A New peptide compound and a process for the preparation thereof
04/10/1996CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same
04/09/1996US5506347 Lyxofuranosyl analogues of adenosine
04/09/1996US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
04/09/1996US5506127 Therapeutic grade thrombin produced by chromatography
04/09/1996US5505908 Adsorbing, desorbing molecular sieve within enclosure, circulation with air
04/05/1996CA2159700A1 Method for the separation of recombinant pro-factor ix from recombinant factor ix
04/04/1996WO1996010042A1 Method of producing starch decomposition products
04/04/1996WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
04/04/1996WO1996010022A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
04/04/1996WO1996009827A2 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
04/04/1996DE4434877A1 Verfahren zur Herstellung von Stärkeabbauprodukten A process for the production of starch degradation products
04/04/1996CA2201355A1 Method of producing starch decomposition products
04/04/1996CA2200436A1 Combination therapy for hypercholesterolemia
04/04/1996CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use
04/04/1996CA2197471A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
04/03/1996EP0704057A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use
04/03/1996EP0703923A1 Factor vii-derived peptides
04/03/1996EP0703904A1 Pyrimidine cyanoguanidines as k-channel blockers
04/03/1996EP0703787A1 Cell growth regulators
04/03/1996CN1119869A N-alkyl-2-substituted ATP analogues
04/03/1996CN1119858A New 4-aminopyridines, process for preparing the same and medicaments containing the same
04/02/1996US5504108 Optically pure 4-aryl-2-hydroxytetronic acids
04/02/1996US5504099 Storage stable aqueous diuretic solution containing azosemide salt of organic amine and biocompatible organic solvent
04/02/1996US5504064 Administering truncated tissue factor protein lacking amino acids that bind to phospholipid membranes with activator of endogenous factor vii to clot blood
04/02/1996US5503850 Large unilamellar vesicles encapsulating a plasminogen activator
03/1996
03/28/1996WO1996009385A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
03/28/1996WO1996009376A1 Therapeutic grade thrombin production and products
03/28/1996WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin
03/28/1996WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
03/28/1996CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
03/27/1996EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
03/27/1996EP0702696A1 Trifunctional antithrombin and antiplatelet peptides
03/27/1996EP0702671A1 Bicyclic fibrinogen antagonists
03/27/1996EP0651747B1 Carbostyryl derivatives
03/27/1996CN1119112A Chinese drug 'Lishuiling capsule' for curing hydrops and preparing process
03/26/1996US5502043 Use of hydroxyethyl starch for improvement of microcirculation
03/26/1996US5502034 Methods for producing thrombin
03/26/1996US5501853 Peptide plasminogen activators
03/26/1996CA1338190C 8,9-ANNELATED-ß-CARBOLINES AND 8,9-ANNELATED-3, 4-DIHYDRO-.BETA.-CAR BOLINES
03/26/1996CA1338189C 8,9-anellated-1,2,3,4-tetrahydro-.beta.-carboline derivatives
03/21/1996WO1996008781A1 System and method of automatically generating chemical compounds with desired properties
03/21/1996WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
03/21/1996WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/21/1996WO1996008271A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996WO1996008250A1 Fibrinogen receptor antagonists
03/21/1996DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 671